Search Results - "Santos Morales, Orestes"

The Position of EGF Deprivation in the Management of Advanced Non-Small Cell Lung Cancer by Crombet Ramos, Tania, Santos Morales, Orestes, Dy, Grace K, León Monzón, Kalet, Lage Dávila, Agustín

“…Advanced non-small cell lung cancer (NSCLC) has faced a therapeutic revolution with the advent of tyrosine kinase inhibitors (TKIs) and immune checkpoints…”
Get full text

Augmenting antibody response to EGF-depleting immunotherapy: Findings from a phase I trial of CIMAvax-EGF in combination with nivolumab in advanced stage NSCLC by Evans, Rachel, Lee, Kelvin, Wallace, Paul K., Reid, Mary, Muhitch, Jason, Dozier, Askia, Mesa, Circe, Luaces, Patricia L., Santos-Morales, Orestes, Groman, Adrienne, Cedeno, Carlos, Cinquino, Aileen, Fisher, Daniel T., Puzanov, Igor, Opyrchal, Mateusz, Fountzilas, Christos, Dai, Tong, Ernstoff, Marc, Attwood, Kristopher, Hutson, Alan, Johnson, Candace, Mazorra, Zaima, Saavedra, Danay, Leon, Kalet, Lage, Agustin, Crombet, Tania, Dy, Grace K.

“…Background CIMAvax-EGF is an epidermal growth factor (EGF)-depleting immunotherapy which has shown survival benefit as a switch maintenance treatment after…”
Get full text

PREVAX: A Phase I Clinical Trial of an EGF-Based Vaccine in Moderate-to-Severe COPD Patients by Hernandez Reyes, Jenysbel de la C, Santos Morales, Orestes, Hernandez Moreno, Laura, Pino Alfonso, Pedro Pablo, Neninger Vinageras, Elia, Knigths Montalvo, Julia Lilliam, Aguilar Sosa, Aliuska, Gonzalez Morera, Amnely, Lorenzo-Luaces Alvárez, Patricia, Aguilar Venegas, Yadira, Troche Concepción, Mayelin, Medel Pérez, Loipa, Santiesteban González, Yanela, García Fernández, Lázara, Regueiro Rodríguez, Lorena, Macías Abrahan, Amparo, Labrada Mon, Mayrel, León Monzón, Kalet, Saavedra Hernández, Danay, Crombet Ramos, Tania

“…EGFR has been suggested to contribute to COPD development and progression. Excessive ligand activation of the receptor leads to epithelial hyperproliferation…”
Get full text

Final results from a phase II trial of CIMAvax-EGF and nivolumab as second-line (2L) therapy after platinum-based chemotherapy in advanced non-small cell lung cancer (NSCLC) by Frascati, Rachel, Early, Amy P., Reid, Mary E., Lee, Kelvin, Muhitch, Jason, Mesa, Circe, Luaces, Patricia Lorenzo, Santos-Morales, Orestes, Dozier, Askia, Puzanov, Igor, Fountzilas, Christos, Gandhi, Shipra, Attwood, Kristopher, Hutson, Alan, Johnson, Candace S., Herrera, Zaima, Saavedra, Danay, Leon, Kalet, Crombet Ramos, Tania, Dy, Grace K.

“…9135 Background: CIMAvax-EGF (C-E) is a recombinant anti-human epidermal growth factor (EGF) depleting immunotherapy which has previously shown increased…”
Get full text

Erythropoietin in Spinocerebellar Ataxia Type 2: Feasibility and Proof‐of‐Principle Issues from a Randomized Controlled Study by Rodriguez‐Labrada, Roberto, Ortega‐Sanchez, Ricardo, Hernández Casaña, Patricia, Santos Morales, Orestes, Padrón‐Estupiñan, Maria del Carmen, Batista‐Nuñez, Maricela, Jiménez Rodríguez, Daise, Canales‐Ochoa, Nalia, Peña Acosta, Arnoy, Medrano Montero, Jacqueline, Labrada Aguilera, Pedro Enrique, Estupiñán Rodriguez, Annelie, Vazquez‐Mojena, Yaimee, Almaguer Gotay, Dennis, Aymed‐García, Judey, García‐García, Idrian, Torres Vega, Reydenis, Viada González, Carmen, Valenzuela Silva, Carmen M., Silva Ricardo, Yanelis, Columbié Ximelis, Jorge, Tribin Rivero, Kenia, Valle Cabrera, Roselin, García‐Rodriguez, Julio Cesar, Crombet Ramos, Tania, Amaro‐González, Daniel, Rodriguez‐Obaya, Teresita, Velázquez‐Pérez, Luis

“…Background Several pieces of evidence have shown the neurotrophic effect of erythropoietin (EPO) and its introduction in the therapeutic practice of…”
Get full text

Safety and effectiveness of CIMAvax-EGF administered in community polyclinics by Ortiz Carrodeguas, Ramón A, Lorenzo Monteagudo, Geidy, Guerra Chaviano, Pedro P, Álvarez Montané, Irene, Salomón Saldívar, Eva E, Lobaina Lambert, Leonardo, Camacho Sosa, Kirenia, Bermúdez Pino, Raúl, Blanco Mustelier, Poncio, Valdés Rodríguez, Elba, González Piloto, Shairis, Guerra de la Vega, Arelys, Valdés Sánchez, Lizet, Montes De Santis, Arasay, Parra Zabala, Jenelly, Viada González, Carmen, Calvo Aguilera, Nadia, Saavedra Hernández, Danay, Santos Morales, Orestes, Crombet Ramos, Tania

“…In spite of the advances in immunotherapy and targeted therapies, lung cancer continues to be the leading cause of cancer-related death. The epidermal growth…”
Get full text

Nasal administration of the neuroprotective candidate NeuroEPO to healthy volunteers: a randomized, parallel, open-label safety study by Santos-Morales, Orestes, Díaz-Machado, Alina, Jiménez-Rodríguez, Daise, Pomares-Iturralde, Yaisel, Festary-Casanovas, Tatiana, González-Delgado, Carlos A, Pérez-Rodríguez, Sonia, Alfonso-Muñoz, Eulalia, Viada-González, Carmen, Piedra-Sierra, Patricia, García-García, Idrian, Amaro-González, Daniel, García-Rodríguez, Julio César, Sosa-Testé, Iliana, Lagarto-Parra, Alicia, Barrero-Viera, Laura, David-Baldo, Marlene, Tamayo-Rodríguez, Maura, Rivero-Vázquez, Ivonne, González-Gamiz, Gricel, Martín-Trujillo, Alis, Rodríguez-Fernández, Yasmila, Ledo-de la Luz, Ana Alfa, Álvarez-Delgado, Maylén, Howland-Álvarez, Ivón, Cruz-Gómez, Yolanda

“…Delivery of therapeutic agents as erythropoietin (EPO) into Central Nervous System through intranasal route could benefit patients with neurological disorders…”
Get full text